DRDGOLD Limited
DRDGOLD Limited (DRDGF) Financial Performance & Income Statement Overview
Analyze DRDGOLD Limited (DRDGF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
DRDGOLD Limited (DRDGF) Income Statement & Financial Overview
View the income breakdown for DRDGOLD Limited DRDGF across both annual and quarterly reports.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $3.80B | $3.27B | $2.97B | $150.34M |
| Cost of Revenue | $2.52B | $2.25B | $2.24B | $102.89M |
| Gross Profit | $1.28B | $1.02B | $734.10M | $47.45M |
| Gross Profit Ratio | $0.34 | $0.31 | $0.25 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $99.30M | $95.80M | $103.50M | $4.88M |
| Operating Expenses | $99.30M | $95.80M | $103.50M | $4.88M |
| Total Costs & Expenses | -$2.62B | $2.34B | $2.34B | $107.77M |
| Interest Income | $132.80M | $125.90M | $154.90M | $9.35M |
| Interest Expense | $6.10M | $11.40M | $8.70M | $925750.00 |
| Depreciation & Amortization | $271.70M | $157.10M | $169.60M | $6.79M |
| EBITDA | $1.58B | $1.21B | $955.70M | $59.26M |
| EBITDA Ratio | $0.42 | $0.37 | $0.32 | $0.33 |
| Operating Income | $1.18B | $923.60M | $630.60M | $42.57M |
| Operating Income Ratio | $0.31 | $0.28 | $0.21 | $0.28 |
| Other Income/Expenses (Net) | $126.70M | $115.90M | -$241.90M | $8.97M |
| Income Before Tax | $1.31B | $1.04B | $777.40M | $51.55M |
| Income Before Tax Ratio | $0.34 | $0.32 | $0.26 | $0.34 |
| Income Tax Expense | $337.10M | $300.10M | $188.10M | $12.06M |
| Net Income | $970.10M | $739.40M | $294.65M | $19.83M |
| Net Income Ratio | $0.26 | $0.23 | $0.10 | $0.26 |
| EPS | $11.20 | $0.86 | $3.42 | $0.23 |
| Diluted EPS | $11.21 | $0.85 | $3.41 | $0.23 |
| Weighted Avg Shares Outstanding | $86.58M | $861.50M | $86.53M | $86.94M |
| Weighted Avg Shares Outstanding (Diluted) | $86.57M | $865.69M | $86.54M | $87.02M |
Financial performance has remained strong, with revenue growing from $150.34M in Q4 2023 to $3.80B in Q2 2025. Gross profit continued to perform well, with margins at 34% in the latest quarter. Operating income reached $1.18B in Q2 2025, holding a steady 31% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.58B. Net income rose to $970.10M, keeping EPS at $11.20. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan